Cargando…

Immune Therapy for Liver Cancers

Hepatocellular carcinoma (HCC) and biliary tract cancers (BTC) display a poor prognosis with 5-year overall survival rates around 15%, all stages taken together. These primary liver malignancies are often diagnosed at advanced stages where therapeutic options are limited. Recently, immune therapy ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hilmi, Marc, Vienot, Angélique, Rousseau, Benoît, Neuzillet, Cindy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016834/ https://www.ncbi.nlm.nih.gov/pubmed/31892230 http://dx.doi.org/10.3390/cancers12010077

Ejemplares similares

Cholangiocarcinoma: the quest for a second-line systemic treatment
por: Vienot, Angélique, et al.
Publicado: (2019)

Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions
por: Hilmi, Marc, et al.
Publicado: (2019)

Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
por: Hilmi, Marc, et al.
Publicado: (2018)

Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
por: Hilmi, Marc, et al.
Publicado: (2020)

Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?
por: Boilève, Alice, et al.
Publicado: (2021)

Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors
por: Hammel, Pascal, et al.
Publicado: (2020)

Professional and Psychological Impacts of the COVID-19 Pandemic on Oncology Residents: A National Survey
por: Hilmi, Marc, et al.
Publicado: (2020)

Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma
por: Neuzillet, Cindy, et al.
Publicado: (2016)

Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
por: Turpin, Anthony, et al.
Publicado: (2022)

Present and Future Research on Anal Squamous Cell Carcinoma
por: Spehner, Laurie, et al.
Publicado: (2021)

Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?
por: Abdeljaoued, Syrine, et al.
Publicado: (2022)

Immune checkpoint therapy in liver cancer
por: Xu, Feng, et al.
Publicado: (2018)

Immune-Mediated Therapies for Liver Cancer
por: Aravalli, Rajagopal N., et al.
Publicado: (2017)

Physical Activity as the Best Supportive Care in Cancer: The Clinician’s and the Researcher’s Perspectives
por: Torregrosa, Cécile, et al.
Publicado: (2022)

Targeting cancer cell metabolism in pancreatic adenocarcinoma
por: Cohen, Romain, et al.
Publicado: (2015)

The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges
por: Muller, Marie, et al.
Publicado: (2022)

Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trial
por: Neuzillet, Cindy, et al.
Publicado: (2015)

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
por: Awang, Zool Hilmi, et al.
Publicado: (2018)

Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective
por: Neuzillet, Cindy, et al.
Publicado: (2023)

Anti-Telomerase CD4(+) Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials
por: Spehner, Laurie, et al.
Publicado: (2020)

Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients
por: Neuzillet, Cindy, et al.
Publicado: (2021)

Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
por: Neuzillet, Cindy, et al.
Publicado: (2013)

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma
por: Aarnink, Anne, et al.
Publicado: (2018)

The Liver–Immunity Nexus and Cancer Immunotherapy
por: Lee, James C., et al.
Publicado: (2022)

A review of new hormonal therapies for prostate cancer in black men: is there enough data?
por: Meunier, Matthias E., et al.
Publicado: (2021)

Epigenetic mechanisms of liver tumor resistance to immunotherapy
por: Sanceau, Julie, et al.
Publicado: (2021)

Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: A nationwide retrospective analysis
por: Neuzillet, Cindy, et al.
Publicado: (2022)

Therapy of Primary Liver Cancer
por: Feng, Mei, et al.
Publicado: (2020)

Cisplatin in Liver Cancer Therapy
por: Hamaya, Sae, et al.
Publicado: (2023)

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
por: Mansi, Laura, et al.
Publicado: (2021)

Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma
por: Neuzillet, Cindy, et al.
Publicado: (2022)

Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinoma
por: Hervé, Laure, et al.
Publicado: (2022)

Immunosuppressive Therapy in Immune-Mediated Liver Disease in the Non-Transplanted Patient
por: Abhyankar, Anita, et al.
Publicado: (2013)

Immunotherapy in Advanced Biliary Tract Cancers
por: Boilève, Alice, et al.
Publicado: (2021)

Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer
por: Delaye, Matthieu, et al.
Publicado: (2022)

CD8(+) CD226(high) T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery
por: Viot, Julien, et al.
Publicado: (2023)

VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy
por: Hilmi, Caroline, et al.
Publicado: (2012)

Pancreatic cancer orthotopic graft in a murine model
por: Muzzolini, Milena, et al.
Publicado: (2023)

Adaptive immunity in the liver
por: Shuai, Zongwen, et al.
Publicado: (2016)

The history of interventional therapy for liver cancer in China
por: Zuo, Mengxuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cr5lk2ei203cbqk5opkkmrgbam